Tracks safety and effectiveness of Medtronic products on the market
Follows people treated with Medtronic devices for heart rhythm, brain, bladder and digestive conditions.
Plain-language title generated from the registry record
Registry title: Product Surveillance Registry
Key facts
- Where
- Athens, Marousi, and Thessaloniki, GreeceSee the 3 sites
Where in Greece
- AthensAthens, GreeceTaking people
- MarousiMarousi, GreeceTaking people
- ThessalonikiThessaloniki, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medtronic
- Trial code
- NCT01524276
- Record updated
- 20 October 2026
- Original description
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.Read full original descriptionShow less
Medtronic Product Surveillance Registry
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Inclusion: Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements; Patient has or is intended to receive or be treated with an eligible Medtronic product; Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient who is, or will be, inaccessible for follow-up; Patient with exclusion criteria required by local law.